Prestige Consumer Healthc...

AI Score

XX

Unlock

82.35
0.23 (0.28%)
At close: Apr 14, 2025, 3:14 PM
0.28%
Bid 82.27
Market Cap 4.08B
Revenue (ttm) 1.12B
Net Income (ttm) 213.94M
EPS (ttm) 4.26
PE Ratio (ttm) 19.33
Forward PE 16.63
Analyst Buy
Ask 82.38
Volume 233,826
Avg. Volume (20D) 365,781
Open 82.69
Previous Close 82.12
Day's Range 81.19 - 82.69
52-Week Range 62.35 - 90.04
Beta 0.47

About PBH

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, ...

Sector Healthcare
IPO Date Feb 10, 2005
Employees 570
Stock Exchange NYSE
Ticker Symbol PBH
Full Company Profile

Analyst Forecast

According to 5 analyst ratings, the average rating for PBH stock is "Buy." The 12-month stock price forecast is $98.5, which is an increase of 19.61% from the latest price.

Stock Forecasts

Next Earnings Release

Prestige Consumer Healthcare Inc. is scheduled to release its earnings on May 8, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+14.78%
Prestige Consumer Healthcare shares are trading hi... Unlock content with Pro Subscription
11 months ago
-7.01%
Prestige Consumer shares are trading lower after the company reported worse-than-expected Q4 financial results and issued weak guidance.